Gideon Blumenthal

Company: Merck

Job title: Vice President of Global Regulatory Affairs for Oncology

Seminars:

10.05 | 7.05 – Regulatory Guidance for Liquid Biopsy Applications in Clinical Programs 10:05 am

Data assembly considerations for regulatory review Regulatory considerations for varying LBx applications and profiling technologies Endpoint considerations in clinical trial design Establishing ctDNA changes as a surrogate marker in the metastatic and adjuvant settingsRead more

day: Day Three